Chart Review of Patients Undergoing Ketamine Infusions

The Canadian Rapid Treatment Centre of Excellence conducted a retrospective analysis of patients treated with intravenous ketamine for primary diagnoses of Major Depressive Disorder, Bipolar Disorder, Post-traumatic Stress Disorder, or Obsessive-Compulsive Disorder to better understand clinical outcomes and safety.

Data cover patients from clinic opening (June 2018) to present; analyses include demographics, diagnosis groups, treatment parameters, response and remission rates, and adverse events recorded in routine clinical care.